Johnson & Johnson1 (NYSE: JNJ) announces it has successfully completed the acquisition of V-Wave Ltd., a privately-held company focused on developing innovative treatment options for patients with heart failure. V-Wave will operate as part of Johnson & Johnson MedTech. The acquisition of V-Wave extends Johnson & Johnson MedTech’s position in cardiovascular disease and provides an even greater opportunity to tackle heart failure, one of the most pressing unmet medical needs in healthcare today.
Read the full article: Johnson & Johnson Completes Acquisition of V-Wave //
Source: https://www.businesswire.com/news/home/20241009736414/en/Johnson-Johnson-Completes-Acquisition-of-V-Wave